NCT06959121View on ClinicalTrials.gov

CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

NANot yet recruitingINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

January 31, 2027

Conditions

Atrial FibrillationMaze ProcedureAFAblation

Interventions

DEVICE

CellFX® nsPFA™ Cardiac Surgery System

Participants will receive cardiac ablation with the CellFX® nsPFA™ Cardiac Clamp

All Listed Sponsors

lead

Pulse Biosciences, Inc.

INDUSTRY

NCT06959121 - CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation | Biotech Hunter | Biotech Hunter